Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Stocks Primed for a Spectacular Comeback in 2024

While investors might be tempted to ride the biggest winners of last year, shifting sands may provide a superior outlook for comeback stocks. Just what…

Dear NEXI Stock Fans, Mark Your Calendars for Jan. 18

Although NexImmune seeks to dissolve its business, NEXI stock is skyrocketing, leading to questions regarding the catalyst.

Why Is Aeva Technologies (AEVA) Stock Up 40% Today?

With autonomous systems specialist Aeva Technologies securing an auto supplier deal, AEVA stock soared on the broader implications.

2023 Year-End Review: Stock Market Triumphs and Turbulences

With another year in the books, it’s time for investors to reassess what worked and what didn’t with a stock market recap. Generally speaking, in…

Real Estate Rebound: Top 3 REITs for Robust Returns in 2024

After a wild year in the books, investors might want to consider the top REITs or real estate investment trusts to buy. Structured as companies…

7 Cryptos to Watch as the Sector Becomes Irrationally Rational

If you want to know where cryptos may be headed in 2024 and beyond, just look at Generation Z. While I hesitate to focus on…

7 Underrated Stock Gems Hiding in Plain Sight

With 2023 being largely about the usual suspects, investors may be better served in the new year targeting under-rated stocks. We’re talking about fundamentally undervalued…

LI Stock Sinks After Li Auto Delays EV Launch

Due to Li Auto delaying the launch of its much-anticipated Mega MPV, the risk of losing market share to competitors hurt LI stock.

Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today?

With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications.

The 3 Hottest Dividend Stocks to Watch in 2024

You know what I hate about the typical article about hottest dividend stocks to watch? You’re excited about adding passive income to your portfolio, only…